Trial Profile
Phase 1 Single-Dose Study of the Pharmacokinetics of Sustained-Release Liothyronine Sodium (T3) in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jun 2014
Price :
$35
*
At a glance
- Drugs Liothyronine (Primary)
- Indications Hypothyroidism
- Focus Pharmacokinetics
- Sponsors IPE
- 16 Jun 2014 New trial record